HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increasing salivary IgA and reducing Streptococcus mutans by probiotic Lactobacillus paracasei SD1: A double-blind, randomized, controlled study.

AbstractBACKGROUND/PURPOSE:
Our previous study revealed that probiotic Lactobacillus paracasei SD1 could reduce mutans streptococci as evaluated by cultivation-method as well as stimulate innate immunity. This study aimed to further investigate the effect of the probiotic on various oral bacteria by real-time PCR and salivary IgA levels.
MATERIALS AND METHODS:
Forty children were included by randomization from either probiotic or control group in the previous study. The probiotic or control received milk-powder with or without L. paracasei SD1, respectively once daily for 6 months. Saliva were collected at baseline 3-, 6-, and 12-months and were evaluated for total bacteria, total lactobacilli (TL), L. paracasei/L. casei (LP/LC), total streptococci (TS) and Streptococcus mutans using the real-time PCR. The salivary IgA (sIgA) was examined using the ELISA method.
RESULTS:
All target bacterial levels were not significantly different at baseline in both groups. After milk-powder consumption, TL and LP/LC levels were significantly increased in the probiotic group, whereas TS and S. mutans levels were significantly decreased compared to baseline. TS and S. mutans levels were significantly lower, while the sIgA was greater in the probiotic compared to the control group. In the probiotic group, a positive correlation was found between LP/LC and sIgA, while negative correlations were observed between TS or S. mutans levels and sIgA.
CONCLUSION:
L. paracasei SD1 could control S. mutans level and could stimulate sIgA. Results indicate that the L. paracasei SD1 strain may have a benefit for prevention of dental caries.
AuthorsNuntiya Pahumunto, Benchamat Sophatha, Supatcharin Piwat, Rawee Teanpaisan
JournalJournal of dental sciences (J Dent Sci) Vol. 14 Issue 2 Pg. 178-184 (Jun 2019) ISSN: 2213-8862 [Electronic] Netherlands
PMID31210892 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: